Takeda America Holdings, a wholly owned subsidiary of Takeda Pharmaceutical Company, has acquired URL Pharma for an upfront payment of $800m. Takeda will begin the integration of URL Pharma and will right away assume responsibility for ...
Takeda America Holdings has entered into an agreement to purchase URL Pharma for an upfront payment of $800m and future performance-based contingent earn out payments. With the completion of the acquisition, URL Pharma will be managed by ...
Tags: Takeda America Holdings, URL Pharma, acute and chronic gout
Takeda's wholly-owned subsidiary, Takeda America Holdings and LigoCyte Pharmaceuticals have entered into a definitive agreement for Takeda to acquire LigoCyte for an upfront payment of $60m, with future contingent consideration based on the ...